THR-beta agonist 4 is a potent THR-beta agonist with significant research potential for treating metabolic diseases such as hyperlipidemia, obesity, hypercholesterolemia, diabetes, steatosis, non-alcoholic steatohepatitis (NASH), and atherosclerosis, as well as other related conditions.
Molekulargewicht:
510.26
CAS Nummer:
[2673409-25-9]
Formel:
C16H11Cl2F2N5O6S
Target-Kategorie:
Thyroid hormone receptor(THR)|||Others
T63515
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten